schisantherin d has been researched along with aflatoxin b1 in 1 studies
| Studies (schisantherin d) | Trials (schisantherin d) | Recent Studies (post-2010) (schisantherin d) | Studies (aflatoxin b1) | Trials (aflatoxin b1) | Recent Studies (post-2010) (aflatoxin b1) |
|---|---|---|---|---|---|
| 9 | 0 | 4 | 4,532 | 49 | 1,715 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, GC; Gao, JL; Li, C; Lin, QY; Liu, SH; Ru, YJ; Wang, L; Wu, JM; Yang, YD; Zhang, XQ; Zheng, CW; Zheng, YX | 1 |
1 other study(ies) available for schisantherin d and aflatoxin b1
| Article | Year |
|---|---|
Schisantherin D from Schisandra chinensis (Turcz.) Baill. exhibits anti-liver fibrosis capacity via modulating ETBR involved signaling, an in vitro and in vivo study.
Topics: Acetaminophen; Aflatoxin B1; Animals; Dioxoles; Humans; Lignans; Liver Cirrhosis; Mice; Molecular Structure; NF-E2-Related Factor 2; Receptor, Endothelin B; Schisandra; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2022 |